Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.389 USD | -4.31% | +4.19% | -32.49% |
May. 09 | Transcript : Virios Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Virios Therapeutics, Inc.
Upcoming events on Virios Therapeutics, Inc.
Past events on Virios Therapeutics, Inc.
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 07:45 am | Q1 2024 Earnings Release |
2024-03-01 11:00 am | Extraordinary Shareholders Meeting |
2024-02-29 09:15 am | Q4 2023 Earnings Release |
2023-11-13 08:30 am | Q3 2023 Earnings Call |
2023-11-13 07:05 am | Q3 2023 Earnings Release |
2023-10-19 11:00 am | ThinkEquity Conference |
2023-09-18 11:00 am | Business Update Call |
2023-08-10 08:30 am | Q2 2023 Earnings Call |
2023-08-10 07:05 am | Q2 2023 Earnings Release |
2023-06-15 11:00 am | Annual General Meeting |
2023-05-11 07:05 am | Q1 2023 Earnings Release |
2023-03-14 07:05 am | Q4 2022 Earnings Release |
2022-12-07 10:00 am | Planet MicroCap Showcase |
2022-11-14 08:30 am | Q3 2022 Earnings Call |
2022-11-14 07:05 am | Q3 2022 Earnings Release |
2022-09-19 08:30 am | IMC-1 Phase 2b Study Results Call |
2022-08-17 10:15 am | Q3 Investor Summit |
2022-08-11 08:30 am | Interim 2022 Earnings Call |
2022-08-11 07:05 am | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -15,6 -17,2 8.99% | -12,3 -13,1 5.8% | -5,45 -6,06 10.05% | -6,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -16,0 -17,1 6.67% | -12,2 -13,1 6.24% | -5,30 -5,95 10.95% | -5,90 |
Net income Million USD | Released Forecast Spread | -10,3 | -16,0 -18,4 13.26% | -12,2 -13,1 6.24% | -5,30 -5,95 10.95% | -5,90 |
EPS USD | Released Forecast Spread | -2,10 | -1,92 -2,21 13.12% | -1,11 -1,18 5.93% | -0,28 -0,32 11.11% | -0,27 |
Announcement Date | 18/03/21 | 17/03/22 | 14/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -4,19 -5,71 26.66% | -3,96 -4,32 8.37% | -3,67 -4,21 12.69% | -2,59 -4,08 36.43% | -2,09 -2,86 26.96% | -1,56 -3,70 57.91% | -1,48 -1,70 13.1% | -1,27 -1,81 29.71% | -1,14 -1,75 35% | -1,40 | -1,60 | -1,70 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,51 -5,68 20.52% | -3,96 -4,49 11.7% | -3,67 -4,21 12.81% | -2,58 -4,08 36.84% | -2,04 -2,86 28.54% | -1,52 -3,70 59% | -1,44 -1,70 15.24% | -1,24 -1,81 31.88% | -1,10 -1,75 37% | -1,30 | -1,60 | -1,70 | |
Net income Million USD | Released Forecast Spread | -4,51 -7,00 35.55% | -3,96 -4,49 11.7% | -3,67 -4,21 12.81% | -2,58 -4,08 36.84% | -2,04 -2,86 28.54% | -1,52 -3,70 59% | -1,44 -1,70 15.24% | -1,24 -1,81 31.88% | -1,10 -1,75 37% | -1,30 | -1,60 | -1,70 | |
EPS USD | Released Forecast Spread | -0,54 -0,83 34.94% | -0,48 -0,54 10.28% | -0,44 -0,51 12.87% | -0,28 -0,49 42.86% | -0,11 -0,16 29.03% | -0,08 -0,20 60% | -0,08 -0,09 11.11% | -0,06 -0,10 36.84% | -0,06 -0,09 33.33% | -0,07 -0,04 -75% | -0,07 | -0,06 | -0,07 |
Announcement Date | 17/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 14/03/23 | 12/05/23 | 10/08/23 | 13/11/23 | 29/02/24 | 09/05/24 | - | - | - |
Past sector events for Virios Therapeutics, Inc.
Today | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
2024-05-14 07:00 am | IMMATICS N.V.: Q1 2024 Earnings Release |
2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
2024-05-14 01:00 am | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VIRI Stock
- Calendar Virios Therapeutics, Inc.